These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10231196)

  • 21. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.
    Sawangjaroen K; Anderson ST; Curlewis JD
    J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary adenylate cyclase-activating polypeptide stimulates secretion in T84 cells.
    Nguyen TD; Heintz GG; Cohn JA
    Gastroenterology; 1992 Aug; 103(2):539-44. PubMed ID: 1321772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase-activating polypeptide stimulates steroidogenesis and adenosine 3',5'-monophosphate accumulation in cultured rat granulosa cells.
    Zhong Y; Kasson BG
    Endocrinology; 1994 Jul; 135(1):207-13. PubMed ID: 8013355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A; Kotoyori J; Oiso Y; Kozawa O
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons.
    Olcese J; McArdle CA; Middendorff R; Greenland K
    J Neuroendocrinol; 1997 Dec; 9(12):937-43. PubMed ID: 9468019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
    Murthy KS; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.
    Delgado M; Ganea D
    J Neuroimmunol; 2000 Oct; 110(1-2):97-105. PubMed ID: 11024538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional type II VIP-PACAP receptors in human airway epithelial-like cells.
    Lindén A; Yoshihara S; Cardell LO; Kaneko T; Stjärne P; Nadel JA
    Peptides; 1997; 18(6):843-6. PubMed ID: 9285933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.
    Gourlet P; Vandermeers-Piret MC; Rathé J; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
    Eur J Pharmacol; 1998 May; 348(1):95-9. PubMed ID: 9650836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line.
    Lema-Kisoka R; Hayez N; Langer I; Robberecht P; Sariban E; Delporte C
    Peptides; 2001 Dec; 22(12):2155-62. PubMed ID: 11786204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.
    Hoo RL; Alexandre D; Chan SM; Anouar Y; Pang RT; Vaudry H; Chow BK
    J Mol Endocrinol; 2001 Oct; 27(2):229-38. PubMed ID: 11564605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
    Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
    Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.
    Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
    J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.